![](https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2022/06/16/industrial_pic_3.jpg)
- The U.S. Defense Health Agency (DHA) has selected Parsons Corp (NYSE:PSN) to provide health-related research and development and additional activities of interest for the Department of Defense and the Military Healthcare System.
- Omnibus IV is a five-year multiple-award IDIQ contract with one five-year option period and a $10 billion ceiling value.
- The Omnibus IV Military Medical Research and Development contract is a continuation of successful past government investments focused on discovering and integrating medical innovations and material solutions.
- Price Action: PSN shares are trading lower by 3.65% at $36.48 on the last check Thursday.